Rachel Batterham

New Capabilities

Active

Lilly's Foundayo won approval in China on November 12 for weight management, making it the first oral GLP-1 pill cleared there for that use. The drug is already approved in the US, the United Arab Emirates and the UK, and European regulators recommended it for obesity and type 2 diabetes on October 15.

Updated 7 hours ago